Status:
COMPLETED
Evaluation of the Effect of 10% Lidocaine Spray Undergoing Coronary Artery Bypass Graft Operation
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Cardiovascular Diseases
Lidocaine Causing Adverse Effects in Therapeutic Use
Eligibility:
All Genders
50-75 years
Phase:
PHASE4
Brief Summary
In patients undergoing coronary bypass surgery; 10% topical lidocaine administered endotracheally before intubation is to investigate the effect of hemodynamic response and EKG paramater after intubat...
Detailed Description
This prospective randomized double-blind study consisted of 60 volunteers undergoing coronary artery bypass surgery. Patients will be randomized and divided into two groups as control (Group C) = 30) ...
Eligibility Criteria
Inclusion
- 50-75 between age patients
- ASA status III patients
- patients undergoing coronary artery bypass graft operation
Exclusion
- cardiomyopathy,
- arrhythmia,
- valvular disease,
- electrolyte disorders
- chronic liver and kidney diseases
- use of medication that led to extended QT intervals
Key Trial Info
Start Date :
May 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03304431
Start Date
May 26 2017
End Date
September 20 2017
Last Update
October 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abant Izzet Baysal University Medical School,
Bolu, Turkey (Türkiye), 14280